Middle-aged women have a lower prevalence and incidence of cardiovascular events compared with men. The mechanisms responsible for this gender-specific difference are unclear. Numeric and functional impairments of bone marrow-derived circulating endothelial progenitor cells (EPCs) are associated with increased cardiovascular and cerebrovascular morbidity and mortality. It is currently unknown whether there are gender-related differences in EPC number and function in middle-aged adults. We tested the hypothesis that EPCs isolated from middle-aged women demonstrate greater colony-forming capacity and migratory activity compared with men of similar age. Peripheral blood samples were collected from 50 sedentary adults, 25 men (59 ؎ 1 years of age) and 25 women (58 ؎ 1 years of age). Mononuclear cells were isolated and preplated for 2 days, and nonadherent cells were further cultured for 7 days to determine EPC colony-forming units. Migratory activity of EPCs was determined using a modified Boyden chamber. The number of EPC colony-forming units was significantly higher (ϳ150%) in samples collected from women (16 ؎ 3) compared with that collected from men (7 ؎ 1). In addition, EPC migration (relative fluorescent units) was ϳ40% greater in women (729 ؎ 74) than in men (530 ؎ 67). In conclusion, these results demonstrate that EPC colony-forming capacity and migratory activity are higher in middle-aged women than in men. Cardiovascular disease is the most frequent cause of death in men and women. However, from 45 to 65 years of age, the prevalence of coronary heart disease and the incidence of myocardial infarction and stroke is ϳ50% higher in men than in women. The mechanisms responsible for this gender-related disparity are currently unclear. Interestingly, there are no apparent gender differences in the incidence and prevalence of traditional cardiovascular disease risk factors, such as hypertension, obesity, tobacco use, hyperlipidemia, diabetes, or sedentary lifestyle in middle-aged adults. 1 Clinical interest in bone marrow-derived circulating endothelial progenitor cells (EPCs) as a novel vascular risk factor has increased due to their importance in vascular repair and noted a relation with endothelial dysfunction and with cardiovascular and cerebrovascular diseases. [2] [3] [4] Decreased EPC number and migratory activity have been linked to atherosclerotic disease progression and cardiovascular events. [5] [6] [7] Currently, it is unknown whether there are gender-specific differences in numeric and functional characteristics of circulating EPCs. Accordingly, we tested the hypothesis that EPCs isolated from middle-aged women would demonstrate greater colony-forming capacity and migratory activity compared with those from men of similar age.
Cardiovascular disease is the most frequent cause of death in men and women. However, from 45 to 65 years of age, the prevalence of coronary heart disease and the incidence of myocardial infarction and stroke is ϳ50% higher in men than in women. The mechanisms responsible for this gender-related disparity are currently unclear. Interestingly, there are no apparent gender differences in the incidence and prevalence of traditional cardiovascular disease risk factors, such as hypertension, obesity, tobacco use, hyperlipidemia, diabetes, or sedentary lifestyle in middle-aged adults. 1 Clinical interest in bone marrow-derived circulating endothelial progenitor cells (EPCs) as a novel vascular risk factor has increased due to their importance in vascular repair and noted a relation with endothelial dysfunction and with cardiovascular and cerebrovascular diseases. [2] [3] [4] Decreased EPC number and migratory activity have been linked to atherosclerotic disease progression and cardiovascular events. [5] [6] [7] Currently, it is unknown whether there are gender-specific differences in numeric and functional characteristics of circulating EPCs. Accordingly, we tested the hypothesis that EPCs isolated from middle-aged women would demonstrate greater colony-forming capacity and migratory activity compared with those from men of similar age.
Methods and Results
Peripheral blood samples were collected from 50 healthy, sedentary adults, 25 men and 25 women. All subjects were nonobese (body mass index Յ30 kg/m 2 ), normotensive, nonsmokers, nonmedicated, and free of overt cardiovascular, metabolic, and hematologic diseases as assessed by medical history, electrocardiograms obtained during exercise and at rest, and fasting blood chemistries. The women were Ն1 year postmenopausal (range 1 to 20) and had never taken or had discontinued use of hormone replacement therapy Ն1 year before the start of the study. Framingham risk score was calculated as previously described. 8 All subjects provided written informed consent according to guidelines of the University of Colorado at Boulder.
EPC colony-forming capacity was determined as previously described. 4, 9 Briefly, peripheral blood mononuclear cells were isolated by Ficoll density-gradient centrifugation (Histopaque 1077, Sigma, St. Louis, Missouri), washed, resuspended in growth medium (Medium 199, Gibco, Grand Island, New York), supplemented with 20% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 mg/ ml), and plated on 6-well plates coated with human fibronectin (BD Biosciences, San Jose, California) for 48 hours. Thereafter, nonadherent cells were collected, and 5 ϫ 10 5 cells were seeded onto 24-well fibronectin-coated plates (BD Biosciences). Growth medium was changed every 3 days, and the colony-forming units (CFUs) were counted in 4 random wells by 2 independent investigators blinded to sample identification on day 7. Only CFUs consisting of multiple, thin, flat cells emanating from a central cluster of rounded cells were counted. Endothelial cell lineage was confirmed in selected samples by fluorescent-activated cell-sorting analysis using antibodies that recognize vascular endothelial growth factor receptor-2, CD34, and CD133.
To determine migration, nonadherent cells (4 ϫ 10 5 ) were resuspended in serum-free culture medium (Medium 199, Gibco) and loaded in the upper chamber of a 24-well modified Boyden chamber coated with fibronectin (FluoroBlok, BD Biosciences). The upper chamber was placed in the lower chamber containing culture medium supplemented with vascular endothelial growth factor (2 ng/ml) and incubated for 22 hours in 5% carbon dioxide at 37°C. Cells were then labeled with calcein AM (Molecular Probes, Eugene, Oregon), and the fluorescence of migrated cells was determined in triplicate with mean relative fluorescent units presented. Plasma concentrations of oxidized lowdensity lipoprotein, C-reactive protein, tumor necrosis factor-␣, and asymmetric dimethylarginine were determined by enzyme immunoassay.
Group differences were determined by analysis of variance. Relations between variables of interest were assessed by Pearson's correlation coefficient and linear regression analysis. Data are reported as mean Ϯ SEM. Statistical significance was set at a p value Ͻ0.05.
Selected subject characteristics are presented in Table 1 . Although none of the subjects were obese, men demonstrated significantly higher body mass and waist circumference, whereas women had higher body fat percentage. Aside from high-density lipoprotein cholesterol, there were no other gender-related differences in metabolic variables or inflammatory cytokines. There were no differences in Framingham risk score between men and the women, but the estimated 10-year coronary heart disease risk was significantly higher in men than in women. We observed no relation between risk score or estimated risk and EPC colony number or migration.
The capacity of EPCs to form colonies was markedly higher (ϳ120%, p Ͻ0.05) in women (16 Ϯ 3 CFUs) than in men (7 Ϯ 1 CFUs; Figure 1 ). There was also a significant gender-related difference in EPC migration. EPC migratory activity was ϳ40% higher in samples from women compared with those from men (729 Ϯ 74 vs 530 Ϯ 67 relative Figure 1) . In each group, no significant univariate correlations were observed between EPC colony formation or migration and any anthropometric, metabolic, or inflammatory variables.
Discussion
The primary new finding of the present study is that EPC colony-forming capacity and migratory activity are markedly higher in middle-age women compared with men. Numeric and functional differences in circulating EPCs may contribute to the gender-related disparity reported in endothelial function 10 and cardiovascular events 1 in this segment of the population.
Circulating EPCs have generated interest as a novel biologic marker of endothelial dysfunction and a prognostic indicator of cardiovascular morbidity and mortality. 4, 7, 11, 12 EPC number (assessed by CFUs or flow cytometry) and migratory activity have been shown to be significantly decreased in patients with coronary and cerebrovascular diseases compared with healthy age-matched controls. 5, 11, 13 Two recent clinical studies have reported that lower levels of circulating EPCs independently predict atherosclerotic disease progression and death from cardiovascular causes in patients with established coronary artery disease. Moreover, after adjusting for disease activity and risk factors, small numbers of circulating EPCs were associated with a fourfold increased risk of a future cardiovascular event. 7, 11 In a seminal study, Hill et al 4 observed a strong correlation between number of EPC CFUs and flow-mediated brachial artery reactivity and overall Framingham risk score in middle-aged men. Importantly, the investigators reported that EPC colony formation was a stronger predictor of endothelial vasodilator function than conventional risk factors, suggesting that a potential mechanism for endothelial dysfunction may be a lack of EPCs to maintain and repair the endothelial monolayer. 12 This postulate is supported by the observation that EPC-mediated vascular repair is associated with normalization of endothelial function at the site of injury. 14 We previously reported, in a similar population of middle-aged adults, that endothelial fibrinolytic capacity is greater in women than in men 10 ; it is tempting to speculate that this difference may be due, at least in part, to EPC bioavailability and bioactivity.
The mechanisms responsible for the gender-related difference in EPC clonogenic potential and migratory activity are unclear. It is important to emphasize that, although a number of pathologic, pharmacologic, and physiologic factors have been reported to influence EPC mobilization and function, all the adults in the present study were free of overt disease, nonmedicated, nonsmokers, and sedentary. In addition, all women were Ն 1 year postmenopausal and not taking estrogen replacement therapy, thus decreasing the potential confounding effect of estrogen-mediated EPC mobilization. Increased levels of oxidative stress, inflammatory cytokines, and asymmetric dimethylarginine, an endogenous inhibitor of endothelial nitric oxide synthase, have been linked to decreased mobilization, differentiation, and function of EPCs. [15] [16] [17] [18] However, we observed no genderrelated differences in these factors in our study population. It is possible that the observed disparity in colony formation and migration represents a primary phenotypic difference between men and women.
